share_log

Merck & Co | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

Merck & Co | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

默沙東 | 11-K:員工持股年度報告
美股SEC公告 ·  06/25 13:40

Moomoo AI 已提取核心訊息

Merck & Co., Inc. (Merck) has filed its Form 11-K annual report for the fiscal year ended December 31, 2023, with the United States Securities and Exchange Commission. The report details the financial performance of the MSD Employee Stock Purchase and Savings Plan, which is designed to facilitate employee investment in Merck stock and savings for the future. The independent audit, conducted by PricewaterhouseCoopers LLP, concluded that the financial statements present fairly the net assets available for benefits as of December 31, 2023, and the changes in net assets for the year in accordance with U.S. accounting principles. The Plan's net assets available for benefits increased from $463.376 million in 2022 to $498.619 million in 2023. The Plan allows eligible employees to contribute a portion of their...Show More
Merck & Co., Inc. (Merck) has filed its Form 11-K annual report for the fiscal year ended December 31, 2023, with the United States Securities and Exchange Commission. The report details the financial performance of the MSD Employee Stock Purchase and Savings Plan, which is designed to facilitate employee investment in Merck stock and savings for the future. The independent audit, conducted by PricewaterhouseCoopers LLP, concluded that the financial statements present fairly the net assets available for benefits as of December 31, 2023, and the changes in net assets for the year in accordance with U.S. accounting principles. The Plan's net assets available for benefits increased from $463.376 million in 2022 to $498.619 million in 2023. The Plan allows eligible employees to contribute a portion of their base pay to invest in various options, including Merck common stock, with the company providing matching contributions. The Plan is subject to ERISA and is administered by committees appointed by Merck's CEO and Board of Directors. The report also includes a summary of the Plan's investment strategies, contributions, participant accounts, and related-party transactions, confirming that the Plan operates in compliance with the Internal Revenue Code and ERISA.
默沙東公司已向美國證券交易委員會提交了其截至2023年12月31日財年的11-K表格年度報告。該報告詳細說明了MSD員工股票購買和儲蓄計劃的財務績效,該計劃旨在促進員工投資默沙東股票併爲未來儲蓄。由普華永道會計師事務所進行的獨立審計結論認爲,2023年12月31日可供福利的淨資產以及符合美國會計準則的本年度淨資產變動情況合理地呈現在了財務報表上。該計劃的可供福利淨資產從2022年的4.63376億美元增加到2023年的4.98619億美元。該計劃允許有資格的員工貢獻部分基本工資來投資於各種期權,包括默沙東普通股,並由公司提供配套貢獻。該計劃受ERISA法規管轄,由默沙東的CEO和董事會委員會管理。該報告還包括該計劃的投資策略摘要、貢獻、參與者帳户以及相關方交易的概述,確認該計劃符合內部收入法典和ERISA的規定。
默沙東公司已向美國證券交易委員會提交了其截至2023年12月31日財年的11-K表格年度報告。該報告詳細說明了MSD員工股票購買和儲蓄計劃的財務績效,該計劃旨在促進員工投資默沙東股票併爲未來儲蓄。由普華永道會計師事務所進行的獨立審計結論認爲,2023年12月31日可供福利的淨資產以及符合美國會計準則的本年度淨資產變動情況合理地呈現在了財務報表上。該計劃的可供福利淨資產從2022年的4.63376億美元增加到2023年的4.98619億美元。該計劃允許有資格的員工貢獻部分基本工資來投資於各種期權,包括默沙東普通股,並由公司提供配套貢獻。該計劃受ERISA法規管轄,由默沙東的CEO和董事會委員會管理。該報告還包括該計劃的投資策略摘要、貢獻、參與者帳户以及相關方交易的概述,確認該計劃符合內部收入法典和ERISA的規定。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息